Aggrenox: a combination of antiplatelet drugs for stroke prevention.
D001241:Aspirin / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000068342:Aspirin, Dipyridamole Drug Combination; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005252:Fees, Pharmaceutical; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
D000068342:Aspirin, Dipyridamole Drug Combination; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin